GIFLF (GIFLF) Stock Price & Analysis
GIFLF (GIFLF) rose 0.00% to USD 11.12 as of June 9, 2026 at 23:47 UTC, according to Nexqual real-time market data.
GIFLF last closed at USD 11.12; the session ranged USD 10.9–11.12 on volume of 425 shares. Market capitalization is $7.57B, with a 52-week range of USD 10.57–14 (PNK). Source: Nexqual, June 9, 2026 at 23:47 UTC.
Key Statistics (as of June 9, 2026 at 23:47 UTC)
| Price | USD 11.12 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 11.12 |
| Open | USD 10.9 |
| Day Range | USD 10.9 – 11.12 |
| 52-Week Range | USD 10.57 – 14 |
| Volume | 425 shares |
| Market Cap | $7.57B |
| Exchange | PNK |
Technical Analysis (GIFLF)
Nexqual's technical model rates GIFLF "BUY" based on 5 bullish and 2 bearish signals across 123 daily candles, as of June 9, 2026 at 23:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 10.95) |
| MACD | 0.07 (positive) |
Analyst Ratings (GIFLF)
Wall Street analysts rate GIFLF "None", per Nexqual as of June 9, 2026 at 23:47 UTC.
| Consensus Rating | None |
|---|
Earnings (GIFLF)
| Revenue Estimate | $1.95B |
|---|
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Financials & Fundamentals (GIFLF)
| Total Revenue | $7.44B |
|---|---|
| Revenue Growth (YoY) | -4.80% |
| Gross Margin | +38.36% |
| Operating Margin | +16.47% |
| Profit Margin | +5.58% |
| ROE | +6.13% |
| Debt / Equity | 123.22 |
| Current Ratio | 2.47 |
| Total Cash | $702.00M |
| Total Debt | $9.67B |
| Free Cash Flow | $887.54M |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Financial Health Score (GIFLF)
Nexqual rates GIFLF's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:47 UTC.
| Growth | Mixed — Revenue +4.3% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 38%, operating 16% |
| Balance Sheet | Mixed — $702M cash vs $9.67B debt |
| Cash Flow | Solid — FCF $888M, 12% margin |
| Efficiency | Mixed — ROE 6%, ROA 4.2% |
Ownership (GIFLF)
| Insider Ownership | +32.15% |
|---|---|
| Institutional Ownership | +40.55% |
| Shares Outstanding | 422.35M |
| Float | 417.32M |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Leadership (GIFLF)
GIFLF is led by Jose Ignacio Abia Buenache (age 57), CEO & Director, per Nexqual as of June 9, 2026 at 23:47 UTC.
| CEO & Director | Jose Ignacio Abia Buenache (age 57) |
|---|---|
| Chief Financial Officer | Rahul Srinivasan (age 48) |
| Senior Vice President of Strategy & COO Office | Lluis Pons Gomez (age 41) |
| Head of Investor Relations & Sustainability and Vice President | Daniel Segarra |
| President of Commercial Tech Support | Sergio Roura Adell (age 56) |
Major Backers & Investors (GIFLF)
Notable institutional backers of GIFLF include DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT., Goldman Sachs, Fidelity, according to Nexqual as of June 9, 2026 at 23:47 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT. | 0.51% |
| Goldman Sachs | 0.32% |
| Fidelity | 0.26% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.63% |
| BlackRock | 1.3% |
| Dimensional Fund Advisors | 0.25% |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GIFOF | Grifols Sa | USD 8.85 | ▲ 0% |
| GIKLY | Grifols Sa | USD 5.39 | ▼ 5.27% |
| DSKYF | Daiichi Sankyo Co., Ltd. | USD 14.96 | ▼ 2.09% |
| ALPMF | Astellas Pharma, Inc. | USD 14.26 | ▲ 0.42% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:47 UTC. This page is informational and not investment advice.